VA Evidence Synthesis Program, VA Portland Health Care System and Oregon Health & Science University, Portland, Oregon (K.M., K.K.K., S.S., D.K.).
VA Evidence Synthesis Program, VA Portland Health Care System, Portland, Oregon (C.K.A., S.Y., J.A., S.V.).
Ann Intern Med. 2021 Mar;174(3):362-373. doi: 10.7326/M20-6306. Epub 2020 Dec 1.
Data suggest that the effects of coronavirus disease 2019 (COVID-19) differ among U.S. racial/ethnic groups.
To evaluate racial/ethnic disparities in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and COVID-19 outcomes, factors contributing to disparities, and interventions to reduce them.
English-language articles in MEDLINE, PsycINFO, CINAHL, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus, searched from inception through 31 August 2020. Gray literature sources were searched through 2 November 2020.
Observational studies examining SARS-CoV-2 infections, hospitalizations, or deaths by race/ethnicity in U.S. settings.
Single-reviewer abstraction confirmed by a second reviewer; independent dual-reviewer assessment of quality and strength of evidence.
37 mostly fair-quality cohort and cross-sectional studies, 15 mostly good-quality ecological studies, and data from the Centers for Disease Control and Prevention and APM Research Lab were included. African American/Black and Hispanic populations experience disproportionately higher rates of SARS-CoV-2 infection, hospitalization, and COVID-19-related mortality compared with non-Hispanic White populations, but not higher case-fatality rates (mostly reported as in-hospital mortality) (moderate- to high-strength evidence). Asian populations experience similar outcomes to non-Hispanic White populations (low-strength evidence). Outcomes for other racial/ethnic groups have been insufficiently studied. Health care access and exposure factors may underlie the observed disparities more than susceptibility due to comorbid conditions (low-strength evidence).
Selection bias, missing race/ethnicity data, and incomplete outcome assessments in cohort and cross-sectional studies must be considered. In addition, adjustment for key demographic covariates was lacking in ecological studies.
African American/Black and Hispanic populations experience disproportionately higher rates of SARS-CoV-2 infection and COVID-19-related mortality but similar rates of case fatality. Differences in health care access and exposure risk may be driving higher infection and mortality rates.
Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development. (PROSPERO: CRD42020187078).
有数据表明,新型冠状病毒病 2019(COVID-19)在美国不同种族/族裔群体中的影响存在差异。
评估严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染率和 COVID-19 结局方面的种族/族裔差异、导致差异的因素以及减少这些差异的干预措施。
在 MEDLINE、PsycINFO、CINAHL、Cochrane 中央对照试验注册库、Cochrane 系统评价数据库和 Scopus 中检索英语文献,检索时间从创建到 2020 年 8 月 31 日。通过 2020 年 11 月 2 日搜索灰色文献来源。
在美国环境中检查 SARS-CoV-2 感染、住院或死亡的种族/族裔的观察性研究。
由两名评审员确认的单 reviewer 提取;对质量和证据强度进行独立的双重评审员评估。
纳入了 37 项质量大多为中等的队列和横断面研究、15 项质量大多为良好的生态学研究以及疾病控制与预防中心和 APM 研究实验室的数据。与非西班牙裔白人人群相比,非裔美国人/黑人以及西班牙裔人群的 SARS-CoV-2 感染、住院和 COVID-19 相关死亡率更高,但病死率(大多报告为住院死亡率)更高(中高强度证据)。亚洲人群的结局与非西班牙裔白人人群相似(低强度证据)。其他种族/族裔群体的研究结果还不够充分。观察到的差异可能更多地归因于卫生保健获取和暴露因素,而不是合并症导致的易感性(低强度证据)。
在队列和横断面研究中必须考虑选择偏倚、缺失的种族/族裔数据和不完全的结局评估。此外,生态学研究缺乏对关键人口统计学协变量的调整。
非裔美国人/黑人以及西班牙裔人群 SARS-CoV-2 感染和 COVID-19 相关死亡率更高,但病死率相似。卫生保健获取和暴露风险的差异可能导致更高的感染率和死亡率。
退伍军人事务部,退伍军人健康管理局,卫生服务研究与发展。(PROSPERO:CRD42020187078)。